The Korea Herald

지나쌤

Bridge Biotherapeutics wins W11.5b investment

By Korea Herald

Published : July 4, 2016 - 17:07

    • Link copied

[THE INVESTOR] Bridge Biotherapeutics announced on July 4 that it has received 11.5 billion won (US$ 10 million) investment from local venture capital firms including LB Investment and KB Investment.

Founded last year, Bridge Biotherapeutics is a local developer of biopharmaceuticals that focuses on commercializing compounds developed or discovered by a third party.

The company is currently working on BBT-401, anti-inflammatory agent discovered by a research team led by Sungkyunkwan University’s professor Park Seok-hee.

By Choi He-suk (cheesuk@heraldcorp.com)